INBX Stock Price, Chart, Stats & News
Inhibrx Biosciences, Inc. (INBX) is a dividend-paying stock with a current dividend yield of 0.00% as of Jul 13, 2026. It pays $0 per share over the trailing twelve months.
Dividend safety
Dividend coverage looks healthy — INBX pays out about 0% of earnings.
INBX chart
Fundamentals
Gross margin | -91.00% |
Operating margin | -10386.54% |
Pretax margin | -10773.31% |
Net margin | -10773.46% |
Effective tax rate | -0.00% |
ROA | -95.62% |
ROE | -269.56% |
D/E | 13.39x |
Interest coverage ratio | -11.07x |
INBX valuation
P/E | – |
P/S | 656.08x |
P/B | 113.13x |
P/CF | -6.97x |
P/FCF | -6.57x |
P/OCF | -6.97x |
PEG | -0.55x |
EV multiple | -6.56x |
About
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P.
Similar securities
Based on sector and market capitalization
